Buy Dabur India, target price Rs 600: Axis Securities - over 1 year ago
Promoters held 67.24 per cent stake in the company as of 30-Sep-2022, while FIIs owned 20.23 per cent, DIIs 6.43 per cent.
Economic Times

Buy HDFC Bank, target price Rs 1840: JM Financial - over 1 year ago
Promoters held 25.73 per cent stake in the company as of 30-Jun-2022, while FIIs owned 40.26 per cent, DIIs 19.16 per cent.
Economic Times

Buy HDFC Bank, target price Rs 1930: Motilal Oswal Financial Services - over 1 year ago
The brokerage estimates a ~19% PAT CAGR over FY22-25, with RoA/RoE at 2.0%/17.7% in FY25. Further, it expects the stock to perform gradually as the margin profile revives and the merger-related overhang eases.
Economic Times

Motilal Oswal Financial Services neutral on Avenue Supermarts; target price Rs 4050 - over 1 year ago
The brokerage estimates an EBITDA/PAT CAGR of 28%/26% over FY23E-25E. value the company at 50x EV/EBITDA on the FY24E basis.
Economic Times

Motilal Oswal Financial Services neutral on Wipro; Target price Rs 380 - over 1 year ago
Motilal Oswal maintains its Neutral stance as it views the current valuation as fair. The brokerage's TP implies 16x FY24E EPS.
Economic Times

Buy HDFC Bank, target price Rs 1869: LKP Securities - over 1 year ago
HDFC Bank, incorporated in the year 1994, is a banking company (having a market cap of Rs 889089.49 Crore).
Economic Times

Sell Indus Towers, target price Rs 172: Nuvama Wealth brokerage - over 1 year ago
On the swing charts, stock has failed to give a bullish follow-through in its recent pullback.
Economic Times

Buy Bajaj Finance, target price Rs 6400: Nuvama Wealth - over 1 year ago
Bajaj Finance, incorporated in the year 1987, is a Large Cap company (having a market cap of Rs 366402.74 Crore) operating in NBFC sector.
Economic Times

Buy IDFC, target price Rs 92 : Nuvama Wealth - over 1 year ago
IDFC has broken out from a “Bullish Flag and Pole”pattern indicating revival of bullish sentiments.i
Economic Times

Buy Infosys, target price Rs 1730 : Sharekhan by BNP Paribas - over 1 year ago
The brokerage maintains a Buy rating on Infosys with an unchanged PT of Rs. 1,730 given strong deal pipeline, its end -to-end capabilities and prowess in digital areas, analytics, automation and Cobalt cloud.
Economic Times

Buy Grasim Industries, target price Rs 1830: Prabhudas Lilladher - over 1 year ago
The stock after the decent correction witnessed has bottomed out near the previous low of 1630 zone to form a double bottom formation pattern on the daily chart and with a small pullback witnessed has shown signs of improving the bias to anticipate for further rise with a trend reversal.
Economic Times

Choice Broking maintains outperform rating on Infosys - over 1 year ago
Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 621685.48 Crore) operating in IT Software sector.
Economic Times

Choice Equity Broking maintains Outperform rating on Cyient - over 1 year ago
Improvements to our EPS expectations lead us to continue ascribing an OUTPERFORM rating with a target price of Rs 1198.
Economic Times

Add HCL Technologies, target price Rs 1207: Choice Equity Broking - over 1 year ago
Due to a recent increase in the stock price and its lower estimates, the brokerage has revised its rating to ADD with a new target price of Rs.1,207 implying a price multiple of 18 on NTM EPS of Rs.67.
Economic Times

Buy Aurobindo Pharma, target price Rs 564: BNP Paribas Securities - over 1 year ago
Promoters held 51.83 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.43 per cent, DIIs 16.55 per cent.
Economic Times

Buy Cyient, target price Rs 1030: HDFC Securities - over 1 year ago
The proposed listing of the DLM (DRHP filed) will lead to value unlocking. For FY23E, the management expects double-digit organic growth, ~14-15% inorganic and EBIT margin of ~13-14%. The brokerage increases its FY24/25E EPS estimate by ~2-4%, led by improving visibility.
Economic Times

Buy Infosys, target price Rs 1815: HDFC Securities - over 1 year ago
Margin levers include large scope for utilisation increase, following strong fresher hiring.
Economic Times

Buy Metropolis Healthcare, target price Rs 1978: BNP Paribas Securities - over 1 year ago
Promoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.
Economic Times

Buy Dr. Lal Pathlabs, target price Rs 2820: BNP Paribas Securities - over 1 year ago
Promoters held 55.05 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.37 per cent, DIIs 6.27 per cent.
Economic Times

Buy Cyient., target price Rs 1100: Motilal Oswal Financial Services - over 1 year ago
Cyient, incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 9975.44 Crore) operating in IT Software sector.
Economic Times